SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: HardToFind who wrote (12449)11/19/2019 8:19:20 PM
From: Savant  Read Replies (2) | Respond to of 12873
 
Don't neglect the possibility that the SEC might have been the ones that put the kibash on the deal...especially considering the 2nd group that was mentioned in re:the financing

fine group, indeed
sonnlaw.com

Even 'considering' Aegis smacks of desperation, or....worse



To: HardToFind who wrote (12449)11/27/2019 10:38:08 PM
From: cacmed1 Recommendation

Recommended By
HardToFind

  Respond to of 12873
 
I think you hit the nail on the head with the licensing agreement. Any investor coming now will want that whole structure revised before investing.

I still think if I were interested I would simply wait until Nano failed and then deal with Theracour.